Aurora Cannabis (ACB) EBITDA (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of EBITDA data on file, last reported at -$681232.0 in Q4 2025.

• EBITDA for Q4 2025 came in at -$681232.0, down 103.51% year-over-year; the trailing twelve-month figure through Dec 2025 was -$70.9 million (down 910.11% YoY), and the FY2025 annual result was $3.4 million, down 74.92% from the prior year.
• EBITDA grew to -$681232.0 in Q4 2025 per ACB's latest filing, from -$38.6 million in the prior quarter.
• Over five years, EBITDA peaked at $58.1 million in Q1 2021 and troughed at -$489.0 million in Q2 2022.
• A 5-year average of -$33.6 million and a median of -$7.2 million in 2021 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2024: EBITDA slumped 2140.82% in 2022, then soared 275.18% in 2024.
• A 5-year view of EBITDA shows it stood at -$5.6 million in 2021, then slumped by 809.55% to -$51.3 million in 2022, then surged by 110.08% to $5.2 million in 2023, then soared by 275.18% to $19.4 million in 2024, then plunged by 103.51% to -$681232.0 in 2025.
• Business Quant data shows ACB's EBITDA at -$681232.0 in Q4 2025, -$38.6 million in Q3 2025, and -$14.8 million in Q2 2025.